These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 19105217)

  • 21. Optimization of spatiotemporal gene inactivation in mouse heart by oral application of tamoxifen citrate.
    Kiermayer C; Conrad M; Schneider M; Schmidt J; Brielmeier M
    Genesis; 2007 Jan; 45(1):11-6. PubMed ID: 17216603
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Generation of tamoxifen-inducible Tfap2b-CreER
    Zhang M; Feng J; Li Y; Qin PZ; Chai Y
    Genesis; 2024 Feb; 62(1):e23582. PubMed ID: 38069547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Cre recombinase alone can induce complete tumor regression.
    Li Y; Choi PS; Casey SC; Felsher DW
    PLoS One; 2014; 9(9):e107589. PubMed ID: 25208064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comment on "Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreER(T2)".
    Uhmann A; Dittmann K; Wienands J; Hahn H
    J Immunol; 2009 Sep; 183(5):2891; author reply 2891-2. PubMed ID: 19696426
    [No Abstract]   [Full Text] [Related]  

  • 25. Tamoxifen-independent recombination in the RIP-CreER mouse.
    Liu Y; Suckale J; Masjkur J; Magro MG; Steffen A; Anastassiadis K; Solimena M
    PLoS One; 2010 Oct; 5(10):e13533. PubMed ID: 21063464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A shortened tamoxifen induction scheme to induce CreER recombinase without side effects on the male mouse skeleton.
    Jardí F; Laurent MR; Dubois V; Khalil R; Deboel L; Schollaert D; Van Den Bosch L; Decallonne B; Carmeliet G; Claessens F; Vanderschueren D
    Mol Cell Endocrinol; 2017 Sep; 452():57-63. PubMed ID: 28504114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation and characterization of tamoxifen-inducible Pax9-CreER knock-in mice using CrispR/Cas9.
    Feng J; Jing J; Sanchez-Lara PA; Bootwalla MS; Buckley J; Wu N; Yan Y; Chai Y
    Genesis; 2016 Sep; 54(9):490-6. PubMed ID: 27381449
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generation and characterization of a tamoxifen-inducible Eomes(CreER) mouse line.
    Pimeisl IM; Tanriver Y; Daza RA; Vauti F; Hevner RF; Arnold HH; Arnold SJ
    Genesis; 2013 Oct; 51(10):725-33. PubMed ID: 23897762
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditional tamoxifen Cre induced mutagenesis in the embryonic kidney in organ culture.
    Jokela T; Vainio S
    Genesis; 2007 Dec; 45(12):757-61. PubMed ID: 18064673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Generation and characterization of a tamoxifen-inducible Vsx1-CreER
    Baudouin C; Pelosi B; Courtoy GE; Achouri Y; Clotman F
    Genesis; 2021 Aug; 59(7-8):e23435. PubMed ID: 34080769
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A New Autosomal
    Deaton RA; Bulut G; Serbulea V; Salamon A; Shankman LS; Nguyen AT; Owens GK
    Arterioscler Thromb Vasc Biol; 2023 Feb; 43(2):203-211. PubMed ID: 36519470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiproliferation and apoptosis induced by tamoxifen in human bile duct carcinoma QBC939 cells via upregulated p53 expression.
    Han P; Kang JH; Li HL; Hu SX; Lian HH; Qiu PP; Zhang J; Li WG; Chen QX
    Biochem Biophys Res Commun; 2009 Jul; 385(2):251-6. PubMed ID: 19460356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RBP-J promotes neuronal differentiation and inhibits oligodendroglial development in adult neurogenesis.
    Fujimoto M; Takagi Y; Muraki K; Nozaki K; Yamamoto N; Tsuji M; Hashimoto N; Honjo T; Tanigaki K
    Dev Biol; 2009 Aug; 332(2):339-50. PubMed ID: 19501584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vegfr3-CreER (T2) mouse, a new genetic tool for targeting the lymphatic system.
    Martinez-Corral I; Stanczuk L; Frye M; Ulvmar MH; Diéguez-Hurtado R; Olmeda D; Makinen T; Ortega S
    Angiogenesis; 2016 Jul; 19(3):433-45. PubMed ID: 26993803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genome Toxicity and Impaired Stem Cell Function after Conditional Activation of CreER
    Bohin N; Carlson EA; Samuelson LC
    Stem Cell Reports; 2018 Dec; 11(6):1337-1346. PubMed ID: 30449703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The platelet-derived growth factor receptor alpha promoter-directed expression of cre recombinase in mouse placenta.
    Wattez JS; Qiao L; Lee S; Natale DRC; Shao J
    Dev Dyn; 2019 May; 248(5):363-374. PubMed ID: 30843624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative evaluation of the strengths and potential caveats of the microglial inducible CreER mouse models.
    Bedolla AM; McKinsey GL; Ware K; Santander N; Arnold TD; Luo Y
    Cell Rep; 2024 Jan; 43(1):113660. PubMed ID: 38217856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tamoxifen dose response and conditional cell marking: is there control?
    Ellisor D; Zervas M
    Mol Cell Neurosci; 2010 Oct; 45(2):132-8. PubMed ID: 20600933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lineage analysis of quiescent regenerative stem cells in the adult brain by genetic labelling reveals spatially restricted neurogenic niches in the olfactory bulb.
    Giachino C; Taylor V
    Eur J Neurosci; 2009 Jul; 30(1):9-24. PubMed ID: 19558606
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen signals via an extra-nuclear pathway involving IGF-1R and EGFR in tamoxifen-sensitive and -resistant breast cancer cells.
    Santen RJ; Fan P; Zhang Z; Bao Y; Song RX; Yue W
    Steroids; 2009 Jul; 74(7):586-94. PubMed ID: 19138696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.